Additionally, changes in dietary patterns during treatment could affect warfarin anticoagulation stability, and closer INR monitoring is warranted
[9] [10] This extended half-life means semaglutide accumulates gradually in your system over several weeks before reaching steady-state concentrations (typically 4-5 weeks)
GIP, an incretin hormone, was not previously considered effective for diabetes treatment
Always follow the administration instructions provided
10.1001/jama.298.2.194 Summary Keywords data mining, FAERS, gastrointestinal adverse events, pharmacovigilance, semaglutide Citation Shu Y, He X, Wu P, Liu Y, Ding Y and Zhang Q (2022) Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system